Neuberger Berman Group Portfolio holdings
Neuberger Berman is an employee-owned investment manager that runs stock, bond, private equity and hedge fund portfolios for institutions, advisers and high net worth individuals. Art collector Roy Neuberger and banker Robert Berman co-founded the firm in 1939. Lehman Brothers bought it in 2003, and after Lehman collapsed in 2008 the firm's own managers won a bankruptcy auction for it, spinning it off in 2009 and returning it to full employee ownership by the end of 2014. Since going independent it has moved beyond its traditional focus on stocks into emerging markets debt, high-yield bonds and private equity, and in 2024 it led a private equity group that agreed to buy the school operator Nord Anglia Education. Art has been part of the firm's workplace culture since Roy Neuberger co-founded it, and it bought back many pieces of its collection at auction in 2010 after Lehman had absorbed them.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$463M |
| 2 |
Apple
AAPL
|
+$418M |
| 3 |
SpaceX
SPCX
|
+$361M |
| 4 |
NVIDIA
NVDA
|
+$291M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$428M |
| 2 |
Microsoft
MSFT
|
+$314M |
| 3 |
Boston Scientific
BSX
|
+$269M |
| 4 |
Teradyne
TER
|
+$249M |
| 5 |
T-Mobile US
TMUS
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.73% |
| 2 | Financials | 12.28% |
| 3 | Industrials | 12.11% |
| 4 | Healthcare | 8.91% |
| 5 | Consumer Discretionary | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2301
Ready Capital
RC
$144M
| $37.3K | ﹤0.01% |
21,332
+2,156
| +11% | +$3.79K |
2025 Q1
5 quarters
|
|
2302
Solid Power
SLDP
$422M
| $36.6K | ﹤0.01% |
+14,134
| New | +$43.6K |
2026 Q2
0 quarters
|
|
2303
Rezolve AI
RZLV
$513M
| $36.4K | ﹤0.01% |
11,547
-337
| -3% | -$887 |
2026 Q1
1 quarter
|
|
2304
Health Catalyst
HCAT
$107M
| $36K | ﹤0.01% |
+18,069
| New | +$26.1K |
2026 Q2
0 quarters
|
|
2305
Pacific Biosciences
PACB
$590M
| $34K | ﹤0.01% |
20,251
-10,690
| -35% | -$15.5K |
2025 Q4
2 quarters
|
|
2306
Cocrystal Pharma
COCP
$19.5M
| $33.5K | ﹤0.01% |
31,886
| – | – |
2025 Q3
3 quarters
|
|
2307
Real REMAX Group Inc. Common Stock
REAX
$415M
| $33.3K | ﹤0.01% |
+1,831
| New | +$37.2K |
2026 Q2
0 quarters
|
|
2308
Sable Offshore Corp
SOC
$145M
| $33.3K | ﹤0.01% |
+10,813
| New | +$138K |
2026 Q2
0 quarters
|
|
2309
3D Systems Corp
DDD
$288M
| $32.5K | ﹤0.01% |
10,765
-1,998
| -16% | -$5.44K |
2025 Q3
3 quarters
|
|
2310
Nkarta
NKTX
$97.4M
| $28.8K | ﹤0.01% |
10,171
-707
| -6% | -$1.99K |
2025 Q4
2 quarters
|
|
2311
Bit Digital
BTBT
$282M
| $28.4K | ﹤0.01% |
15,772
+4,464
| +39% | +$7.86K |
2025 Q4
2 quarters
|
|
2312
Alector
ALEC
$372M
| $27.2K | ﹤0.01% |
13,521
-1,007
| -7% | -$2.16K |
2025 Q4
2 quarters
|
|
2313
Protalix BioTherapeutics
PLX
$251M
| $27K | ﹤0.01% |
11,580
-49
| -0.4% | -$104 |
2026 Q1
1 quarter
|
|
2314
Clean Energy Fuels
CLNE
$428M
| $23.7K | ﹤0.01% |
11,578
-811
| -7% | -$1.72K |
2025 Q2
4 quarters
|
|
2315
Clarivate
CLVT
$1.52B
| $23K | ﹤0.01% |
10,636
-33,777
| -76% | -$82.6K |
2026 Q1
1 quarter
|
|
2316
AMC Entertainment Holdings
AMC
$2.89B
| $22.4K | ﹤0.01% |
+11,814
| New | +$20.3K |
2026 Q2
0 quarters
|
|
2317
ADC Therapeutics
ADCT
$214M
| $22.1K | ﹤0.01% |
+20,661
| New | +$60.3K |
2026 Q2
0 quarters
|
|
2318
8x8 Inc
EGHT
$331M
| $21.2K | ﹤0.01% |
12,377
-262
| -2% | -$527 |
2025 Q4
2 quarters
|
|
2319
Coherus Oncology
CHRS
$84.1M
| $20.1K | ﹤0.01% |
14,388
-287
| -2% | -$469 |
2025 Q1
5 quarters
|
|
2320
Geron
GERN
$629M
| $19.9K | ﹤0.01% |
15,575
-9,806
| -39% | -$13.8K |
2026 Q1
1 quarter
|
|
2321
Black Diamond Therapeutics
BDTX
$91.4M
| $19.4K | ﹤0.01% |
+10,473
| New | +$25.6K |
2026 Q2
0 quarters
|
|
2322
Quantum-Si Incorporated
QSI
$259M
| $19.3K | ﹤0.01% |
+21,766
| New | +$20.7K |
2026 Q2
0 quarters
|
|
2323
SmartRent
SMRT
$325M
| $17.8K | ﹤0.01% |
14,937
| – | – |
2025 Q4
2 quarters
|
|
2324
Heron Therapeutics
HRTX
$63.4M
| $16.6K | ﹤0.01% |
+38,987
| New | +$31.3K |
2026 Q2
0 quarters
|
|
2325
GoPro
GPRO
$133M
| $16.5K | ﹤0.01% |
+21,252
| New | +$22.5K |
2026 Q2
0 quarters
|
|
Similar funds
Neuberger Berman Group's Q2 2026 Portfolio in Review
As of Q2 2026, Neuberger Berman Group held 2,421 positions worth $150B, up 14% from $131B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Neuberger Berman Group's Q2 2026 filing shows 259 new, 1,157 increased, 848 reduced and 81 closed positions. Its largest new stake was SpaceX: 2,127,228 shares worth $363M. The largest sale was Advanced Micro Devices, an estimated $428M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Neuberger Berman Group's largest Q2 2026 buy was SpaceX: 2,127,228 shares worth $363M.
- Neuberger Berman Group added most to Amazon in Q2 2026, an estimated $463M increase.
- Neuberger Berman Group's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $428M.
- Neuberger Berman Group fully exited Hologic in Q2 2026, selling an estimated $103M.
- Neuberger Berman Group's ten largest holdings make up 23% of its $150B portfolio in Q2 2026.
- Neuberger Berman Group opened 259 new positions and closed 81 in Q2 2026.
- Neuberger Berman Group's portfolio value rose 14% quarter-over-quarter to $150B.
Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.